<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04478578</url>
  </required_header>
  <id_info>
    <org_study_id>BAC20001</org_study_id>
    <nct_id>NCT04478578</nct_id>
  </id_info>
  <brief_title>Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia</brief_title>
  <acronym>SEACTN-WP-A</acronym>
  <official_title>Determining the Incidence, Causes and Outcomes of Rural Febrile Illness (RFI) in South and Southeast Asia, as Part of the South and Southeast Asian Community-based Trials Network (SEACTN). Work Package A (WP-A).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical Action Myanmar</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shoklo Malaria Research Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Building Resources Across Communities (BRAC), Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mahidol Oxford Tropical Medicine Research Unit</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Action for Health Development (AHEAD)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will collect information to understand the causes and outcomes of febrile illness&#xD;
      in rural areas in countries across South and Southeast Asia ( including Cambodia, Laos,&#xD;
      Myanmar and Bangladesh). The findings will be used to identify new tests and treatments that&#xD;
      can improve the management of febrile patients in the future.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to better understand and quantify the burden of febrile illness, the&#xD;
      aetiological causes and the manner in which it affects the people living in rural areas in&#xD;
      South and Southeast Asia, all on a scale which has not been attempted before. The SEACTN RFI&#xD;
      project will collect information to help better understand and predict these outcomes based&#xD;
      on a multitude of factors, which will form the basis for interventions within the network in&#xD;
      the future. Determining the incidence, causes and outcomes of febrile illness in these&#xD;
      settings will be done through two work packages. The first of these, Work Package A (WP-A),&#xD;
      the subject of this study, will be carried out at the community level, primarily by engaging&#xD;
      village health worker (VHWs) and low-level Health Centres (HCs) which serve the communities&#xD;
      to recruit patients presenting with a febrile illness. These patients will be assessed for&#xD;
      presenting symptoms and followed up for clinical outcomes. Collection of specimen for&#xD;
      diagnostic investigations in these settings is challenging. Currently, mRDTs are conducted by&#xD;
      VHWs and HCs in these networks, therefore by using the same process, but also applying blood&#xD;
      to filter paper and allowing it to dry (DBS), investigators will test for certain other&#xD;
      pathogens, which will increase the aetiological yield.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 4, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Local incidence of febrile illness</measure>
    <time_frame>From Months 0 to 24</time_frame>
    <description>The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the village level.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall incidence of febrile illness</measure>
    <time_frame>From Months 0 to 24</time_frame>
    <description>The incidence per year that an individual seeks care for a febrile illness with the village health workers or local health facility, at the regional level. These estimates will later be triangulated with and extrapolated from using health seeking behavior surveys for an estimate of the total incidence of febrile illness.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>Within approximately 1 month of first presentation to the village health worker or health facility</time_frame>
    <description>Case fatality rates in febrile illness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morbidity</measure>
    <time_frame>Over 1 month after first presentation</time_frame>
    <description>Duration of illness in patients presenting with a fever to the village health worker or health facility.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of pathogens in febrile patients</measure>
    <time_frame>Samples collected over approximately 24 months</time_frame>
    <description>Pathogens will be detected in patients presenting over a 24 month period using point of care tests and diagnostic assays on acute and convalescent dried blood spots.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The correlation between host biomarker concentrations, aetiological diagnoses and clinical outcomes.</measure>
    <time_frame>Samples collected over approximately 24 months</time_frame>
    <description>The area under the curve, sensitivity and specificity of host biomarkers to identify bacterial infections and to predict severe outcomes.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Febrile Illness</condition>
  <arm_group>
    <arm_group_label>Patients with febrile illness</arm_group_label>
    <description>Participants from approximately 650 villages, with a target number of 100,000 episodes of febrile illness, will be enrolled into this study.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Dried blood spots (DBS)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an acute febrile illness of all ages presenting to village health workers&#xD;
        (VHWs) or peripheral health facilities.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Documented fever (≥ 37.5°C axillary), hypothermia (&lt; 35.5°C) and/or history of fever&#xD;
             in the last 24 hours.&#xD;
&#xD;
          -  Willingness and ability to comply with study protocol for the study duration.&#xD;
&#xD;
          -  Written informed consent given to participate in the trial.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Currently enrolled in the study&#xD;
&#xD;
          -  Accident or trauma is the cause for presentation&#xD;
&#xD;
          -  Presentation ≤ 3 days after routine immunisations&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoel Lubell, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol Oxford Tropical Medicine Research Unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yoel Lubell, Prof.</last_name>
    <phone>+66-857201350</phone>
    <email>yoel@tropmedres.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Building Resources Across Communities (BRAC)</name>
      <address>
        <city>Dhaka</city>
        <zip>1212</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aninda Sen, MBBS | MPH</last_name>
      <phone>(+880) 171 131 9050</phone>
      <email>aninda.sen@brac.net</email>
    </contact>
    <contact_backup>
      <last_name>Amit Neogi, Masters</last_name>
      <phone>(+880) 179 220 5401</phone>
      <email>amit.kn@brac.net</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Action for Health Development (AHEAD)</name>
      <address>
        <city>Battambang</city>
        <country>Cambodia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vanna Moul, MD</last_name>
      <phone>(+85) 553 900 898</phone>
      <email>vanna@ahead.org.kh</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Peto, PhD</last_name>
      <phone>(+66) 802 187 460</phone>
      <email>tom@tropmedres.ac</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)</name>
      <address>
        <city>Vientiane</city>
        <state>Vientiane Prefecture</state>
        <zip>01000</zip>
        <country>Lao People's Democratic Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Koukeo Phommasone, PhD</last_name>
      <phone>+(85) 620 558 42842</phone>
      <email>Koukeo@tropmedres.ac</email>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Ashley, Prof.</last_name>
      <phone>(+85) 621 250 752</phone>
      <email>liz@tropmedres.ac</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical Action Myanmar (MAM)</name>
      <address>
        <city>Yangon</city>
        <zip>11201</zip>
        <country>Myanmar</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aye Sandar Zaw, MSc</last_name>
      <phone>(+95) 95133262</phone>
      <email>ayesandarzaw@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Htet Htet Aung, BA</last_name>
      <phone>(+95) 9421108636</phone>
      <email>htethtetaung.mocru@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mahidol VivaResearch Unit, Faculty of Tropical Medicine, Mahidol University (MVRU)</name>
      <address>
        <city>Ratchathewi</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wanlapa Roobsoong, Ph.D</last_name>
      <phone>(+66) 632 137 409</phone>
      <email>wanlapa.ros@mahidol.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dr. Jetsumon Prachumsri</last_name>
      <phone>+66 (0) 2306 9187</phone>
      <email>jetsumon.pra@mahidol.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Shoklo Malaria Research Unit (SMRU)</name>
      <address>
        <city>Mae Sot</city>
        <state>Tak</state>
        <zip>63110</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aung Pyae Phyo, DPhil</last_name>
      <phone>055 532 026</phone>
      <email>aungpyaephyo@tropmedres.ac</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chiangrai Clinical Research Unit (CCRU)</name>
      <address>
        <city>Chiang Rai</city>
        <zip>57000</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlo Perrone, MD</last_name>
      <phone>(+66) 985 340 823</phone>
      <email>Carlo@tropmedres.ac</email>
    </contact>
    <contact_backup>
      <last_name>Nidanuch Tasak, Bachelor</last_name>
      <phone>(+66) 910 719 036</phone>
      <email>nidanuch@tropmedres.ac</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Bangladesh</country>
    <country>Cambodia</country>
    <country>Lao People's Democratic Republic</country>
    <country>Myanmar</country>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 9, 2020</study_first_submitted>
  <study_first_submitted_qc>July 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2020</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Febrile Illness</keyword>
  <keyword>Incidence</keyword>
  <keyword>Causes</keyword>
  <keyword>Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperthermia</mesh_term>
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.</ipd_description>
    <ipd_time_frame>After completion of trial activities and reporting</ipd_time_frame>
    <ipd_access_criteria>MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

